Express Scripts

Last up is Express Scripts ( ESRX), a stock that rallied yesterday following news that the firm's planned merger with Medco Health Solutions went through successfully. The merger had been a major black cloud over the firm, as regulatory interference could have been costly for the firm. Now, with investor ennui shaken out of ESRX, this stock is in breakout mode.

Shares of ESRX had been consolidating in a channel for much of 2012, stuck in between a narrow range of support at $52 and resistance at $55. But the news that the Medco merger went though was enough to push ESRX through that price ceiling. That's sending a buy signal in shares of this pharmacy benefit manager right now. The breakout keeps this stock in the uptrend that's defined shares in 2012 -- that same uptrend should keep ESRX on track for gains in April.

If you decide to be a buyer at this point, I'd recommend keeping a protective stop at the 50-day moving average.

To see these plays in action, check out the Technical Setups for the Week portfolio at Stockpickr.

-- Written by Jonas Elmerraji in Baltimore.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Jonas Elmerraji is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on

If you liked this article you might like

Here's How to Invest Like a Billionaire

The Dow Binges on Earnings

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens